AMSTERDAM - Philips, a Dutch health technology company, has recently told that they would start fixing and substituting millions of respiratory machines in the United States and other markets to address the potential health risks caused by the machines.
Earlier, the company dismissed almost four million respiratory devices and ventilators as a foam part of the devices has the potency to degrade, become toxic, and cause cancer.
Philips had received authorisation from the U.S. Food and Drug Administration (FDA) to revise the affected DreamStation device, replacing the sound declining foam with new material.
Philips said that more than half of the affected machines had been sold in the U.S., and the full replacement effort will take about a year.
(Reporting by Bart Meijer)
